124 related articles for article (PubMed ID: 28100632)
21. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
Kitano M; Davidson GW; Shirley LA; Schmidt CR; Guy GE; Khabiri H; Dowell JD; Shah MH; Bloomston M
Ann Surg Oncol; 2016 Nov; 23(12):4008-4015. PubMed ID: 27393568
[TBL] [Abstract][Full Text] [Related]
22. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.
Roche A; Girish BV; de Baère T; Baudin E; Boige V; Elias D; Lasser P; Schlumberger M; Ducreux M
Eur Radiol; 2003 Jan; 13(1):136-40. PubMed ID: 12541121
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases.
Yoo JJ; Lee JH; Lee SH; Lee M; Lee DH; Cho Y; Lee YB; Yu SJ; Kim HC; Kim YJ; Yoon JH; Kim CY; Lee HS
PLoS One; 2014; 9(11):e113926. PubMed ID: 25427152
[TBL] [Abstract][Full Text] [Related]
24. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
25. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
Poggi G; Quaretti P; Minoia C; Bernardo G; Bonora MR; Gaggeri R; Ronchi A; Saluzzo CM; Azzaretti A; Rodolico G; Montagna M; Amatu A; Teragni C; Palumbo I; Traverso E; Tonini S; Villani L; Scelsi M; Baiardi P; Felisi MG; Sottotetti F; Tagliaferri B; Riccardi A
Anticancer Res; 2008; 28(6B):3835-42. PubMed ID: 19192637
[TBL] [Abstract][Full Text] [Related]
26. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
[TBL] [Abstract][Full Text] [Related]
27. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.
Vogl TJ; Mack MG; Balzer JO; Engelmann K; Straub R; Eichler K; Woitaschek D; Zangos S
Radiology; 2003 Nov; 229(2):457-64. PubMed ID: 14500854
[TBL] [Abstract][Full Text] [Related]
28. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.
Murthy R; Kamat P; Nunez R; Madoff DC; Gupta S; Salem R; Yao JC
J Vasc Interv Radiol; 2008 Jan; 19(1):145-51. PubMed ID: 18192482
[TBL] [Abstract][Full Text] [Related]
29. Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.
Lee SW; Lee HL; Han NI; Jang JW; Bae SH; Choi JY; Yoon SK
Cancer Chemother Pharmacol; 2017 Jan; 79(1):81-88. PubMed ID: 27913882
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
[TBL] [Abstract][Full Text] [Related]
31. Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
Zhou J; Liu Y; Ren Z; Zhang Y; Zhang M
J Cancer Res Ther; 2017; 13(5):767-772. PubMed ID: 29237901
[TBL] [Abstract][Full Text] [Related]
32. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor.
Waters KM; Ali SZ; Erozan YS; Olson MT
Diagn Cytopathol; 2015 Jan; 43(1):45-8. PubMed ID: 24550155
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
[TBL] [Abstract][Full Text] [Related]
34. Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes.
Rostas J; Tam A; Sato T; Kelly L; Tatum C; Scoggins C; McMasters K; Martin RCG
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1392-1400. PubMed ID: 28508253
[TBL] [Abstract][Full Text] [Related]
35. Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience.
Dhir M; Shrestha R; Steel JL; Marsh JW; Tsung A; Tublin ME; Amesur NB; Orons PD; Santos E; Geller DA
Ann Surg Oncol; 2017 Feb; 24(2):450-459. PubMed ID: 27663565
[TBL] [Abstract][Full Text] [Related]
36. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
Xu JY; Murphy WA; Milton DR; Jimenez C; Rao SN; Habra MA; Waguespack SG; Dadu R; Gagel RF; Ying AK; Cabanillas ME; Weitzman SP; Busaidy NL; Sellin RV; Grubbs E; Sherman SI; Hu MI
J Clin Endocrinol Metab; 2016 Dec; 101(12):4871-4877. PubMed ID: 27662441
[TBL] [Abstract][Full Text] [Related]
37. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
[TBL] [Abstract][Full Text] [Related]
38. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
[TBL] [Abstract][Full Text] [Related]
39. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
